PolyProx

About:

PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.

Website: https://www.polyprox.com/

Twitter/X: polyprox

Top Investors: Cambridge Innovation Capital, Future Planet Capital, LifeArc, Parkwalk Advisors, University of Cambridge Enterprise

Description:

PolyProx Therapeutics is developer of a novel class of drug intended to provide new therapies for cancer treatment. The company's drug will use novel engineered protein that is able to selectively target tumour cells and trigger natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and remove disease-causing proteins.